Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,511 | -32,829 | -89,756 | -60,516 | -37,995 |
| Depreciation Amortization | 483 | 189 | 646 | 455 | 307 |
| Accounts payable and accrued liabilities | 612 | 3,679 | -53 | 2,007 | 478 |
| Other Working Capital | -370 | -1,700 | 12,862 | 15,736 | 934 |
| Other Operating Activity | 9,530 | 2,438 | 11,954 | 5,320 | 4,230 |
| Operating Cash Flow | $-51,256 | $-28,223 | $-64,347 | $-36,998 | $-32,046 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 33,807 | -16,064 | 7,633 | 30,947 | 13,922 |
| Other Investing Activity | 129 | 0 | 39 | 0 | 0 |
| Investing Cash Flow | $33,936 | $-16,064 | $7,672 | $30,947 | $13,922 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,622 | 3,814 | 9,281 | 6,575 | 4,623 |
| Other Financing Activity | -54,485 | 0 | 74,769 | 27,126 | -146 |
| Financing Cash Flow | $-49,863 | $3,814 | $84,050 | $33,701 | $4,477 |
| Beginning Cash Position | 112,584 | 112,584 | 85,209 | 85,209 | 85,209 |
| End Cash Position | 45,401 | 72,111 | 112,584 | 112,859 | 71,562 |
| Net Cash Flow | $-67,183 | $-40,473 | $27,375 | $27,650 | $-13,647 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,256 | -28,223 | -64,347 | -36,998 | -32,046 |
| Free Cash Flow | -51,256 | -28,223 | -64,347 | -36,998 | -32,046 |